Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desoximetasone 0.25% Spray in Moderate to Severe Plaque Psoriasis
NCT01206660Phase 3Completed
- Start
- Aug 2010
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in plaque psoriasis comparing Desoximetasone Spray 0.25% with Placebo (2 arms). Primary endpoints: Clinical Success ITT at 28 days and Treatment Success at Day 28. Started Aug 2010; status: completed.
02
Drugs
desoximetasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01206660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01206660.